-
21.
公开(公告)号:CA2302832A1
公开(公告)日:2000-02-03
申请号:CA2302832
申请日:1999-07-19
Applicant: KANEKA CORP
Inventor: KINOSHITA KOICHI , MOROSHIMA TADASHI , UEDA YASUYOSHI , FUSE YOSHIHIDE , YANAGIDA YOSHIFUMI
Abstract: A method for crystallizing the maleic acid salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline (Enalapril) from an aqueous liquid with ease in good yield, which comprises mixing an aqueous liquid containing N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline, maleic acid and a base and having a pH of 4 or more with an acid in an amount of the acid sufficient to convert the base to a neutral salt, to thereby crystallize N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline in the form of a maleic acid salt.
-
公开(公告)号:HU227816B1
公开(公告)日:2012-03-28
申请号:HU0001145
申请日:1998-07-21
Applicant: KANEKA CORP
Inventor: MOROSHIMA TADASHI , UEDA YASUYOSHI , KINOSHITA KOICHI , YANAGIDA YOSHIFUMI , FUSE YOSHIHIDE
Abstract: Preparation of salts of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acid derivatives of formula (R1)NH-CH(R2)-CO2H (I) comprises: (a) condensing an amino acid with N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine N-carboxyanhydride of formula (II), under basic conditions; (b) decarboxylating the condensate under neutral to acidic conditions to give (I); and (c) and converting (I) to its salt. Steps (a), (b) and optionally (c) are carried out in aqueous liquid to inhibit the formation of by-products of formula (III): -N(R1)CH(R2)-C(O)- = e.g. group of formula (i).
-
公开(公告)号:CA2555976A1
公开(公告)日:2005-09-15
申请号:CA2555976
申请日:2005-03-03
Applicant: PROCTER & GAMBLE , KANEKA CORP
Inventor: YEE KENNETH , NODA ISAO , OSAKADA FUMIO , YANAGIDA YOSHIFUMI , UEDA YASUYOSHI , CEARLEY ANGELLA CHRISTINE , NARASIMHAN KARUNAKARAN , KINOSHITA KOICHI
Abstract: A process for easily producing a biodegradable polyhydroxyalkanoate accordin g to a solvent extraction technique without inviting of a substantial decrease of molecular weight. There is provided a process for producing polyhydroxyalkanoate, characterized in that polyhydroxyalkanoate is extracte d from a polyhydroxyalkanoate-containing biomass of 5 wt.% or less water conte nt with the use of an extraction solvent, crystallized and recovered.
-
公开(公告)号:DE69830307D1
公开(公告)日:2005-06-30
申请号:DE69830307
申请日:1998-07-21
Applicant: KANEKA CORP
Inventor: UEDA YASUYOSHI , KINOSHITA KOICHI , MOROSHIMA TADASHI , YANAGIDA YOSHIFUMI , FUSE YOSHIHIDE
Abstract: Preparation of salts of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acid derivatives of formula (R1)NH-CH(R2)-CO2H (I) comprises: (a) condensing an amino acid with N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine N-carboxyanhydride of formula (II), under basic conditions; (b) decarboxylating the condensate under neutral to acidic conditions to give (I); and (c) and converting (I) to its salt. Steps (a), (b) and optionally (c) are carried out in aqueous liquid to inhibit the formation of by-products of formula (III): -N(R1)CH(R2)-C(O)- = e.g. group of formula (i).
-
公开(公告)号:DE60008334D1
公开(公告)日:2004-03-25
申请号:DE60008334
申请日:2000-04-14
Applicant: KANEKA CORP
Inventor: KINOSHITA KOICHI , MOROSHIMA TADASHI , YANAGIDA YOSHIFUMI , NAGASHIMA NOBUO , SAKA YASUHIRO , HONDA TATSUYA , FUSE YOSHIHIDE , UEDA YASUYOSHI
IPC: C07C29/147 , C07C31/42 , C07D307/20
Abstract: The application is concerned with a process for producing a 3-hydroxytetrahydrofuran of the formula (3): by cyclizing a 4-halo-1,3-butanediol of the general formula (2): wherein X represents a halogen atom in an aqueous solution, which comprises carrying out the cyclization reaction under weakly acidic to neutral conditions. Furthermore several methods are disclosed for the isolution of highly pure 3-hydroxytetrahydrofuran.
-
公开(公告)号:CZ20001897A3
公开(公告)日:2000-10-11
申请号:CZ20001897
申请日:1999-09-22
Applicant: KANEKA CORP
Inventor: MOROSHIMA TADASHI , YANAGIDA YOSHIFUMI , FUSE YOSHIHIDE , UEDA YASUYOSHI
Abstract: The process for producing N -(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline in a simple, efficient and industrially advantageous manner, which comprises: the first step of subjecting the N -(1(S)-alkoxycarbonyl-3-phenylpropyl)-N -trifluoroacetyl-L-lysyl -L-proline (1) to alkali hydrolysis in a mixed solution composed of water and a hydrophilic organic solvent using an inorganic base in an amount of n molar equivalents (n >/= 3) per mole of the above compound (1), the second step of neutralizing the hydrolysis product using an inorganic acid in an amount of (n - 1) to n molar equivalents (n >/= 3) and removing the inorganic salt formed by causing the same to precipitate out from a solvent system suited for decreasing the solubility of the inorganic salt, and the third step of causing the compound (2) existing in the mixture after removal of the inorganic salt to crystallize out at the isoelectric point thereof and thereby recovering the compound (2) in the form of crystals while retaining the salts comprising the trifluoroacetic acid-derived organic acid salt in a state dissolved in the mother liquor.
-
公开(公告)号:SI9820007A
公开(公告)日:1999-10-31
申请号:SI9820007
申请日:1998-07-21
Applicant: KANEKA CORP
Inventor: UEDA YASUYOSHI , KINOSHITA KOICHI , MOROSHIMA TADASHI , YANAGIDA YOSHIFUMI , FUSE YOSHIHIDE
Abstract: There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine.N-carboxy anhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3) is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
-
公开(公告)号:CA2266757A1
公开(公告)日:1999-02-04
申请号:CA2266757
申请日:1998-07-21
Applicant: KANEKA CORP
Inventor: UEDA YASUYOSHI , KINOSHITA KOICHI , MOROSHIMA TADASHI , FUSE YOSHIHIDE , YANAGIDA YOSHIFUMI
Abstract: A process for preparing pharmacologically acceptable salts of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids, comprising the steps of: condensing an amino acid with N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine N-carboxyanhydride under basic conditions; decarboxylating the condensate under neutral to acidic conditions to prepare an N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acid; and converting the product to a pharmacologically acceptable salt thereof, characterized in that a series of procedures up to the formation of a pharmacologically acceptable salt or up to the withdrawal of the pharmaceutically acceptable salt thereof are carried out in an aqueous liquid to inhibit the production of a by-product (3). According to this process, high-quality pharmacologically acceptable salts of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids can be prepared in high yields in a cost-effective manner on a commercial scale.
-
公开(公告)号:CA2266757C
公开(公告)日:2010-10-19
申请号:CA2266757
申请日:1998-07-21
Applicant: KANEKA CORP
Inventor: UEDA YASUYOSHI , KINOSHITA KOICHI , MOROSHIMA TADASHI , YANAGIDA YOSHIFUMI , FUSE YOSHIHIDE
Abstract: There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)--ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N--(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine- N-carboxy-anhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3): (see formula 3) is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
-
公开(公告)号:SI9820007B
公开(公告)日:2007-12-31
申请号:SI9820007
申请日:1998-07-21
Applicant: KANEKA CORP
Inventor: UEDA YASUYOSHI , KINOSHITA KOICHI , MOROSHIMA TADASHI , YANAGIDA YOSHIFUMI , FUSE YOSHIHIDE
Abstract: Podan je postopek za pripravo farmakološko sprejemljive soli N-(1(S)-etoksikarbonil-3-fenilpropil)-L-alanil-aminokisline, ki obsega kondenziranje aminokisline in N-(1(S)-etoksikarbonil-3-fenilpropil)-L-alanin.N-karboksianhidrida pod bazičnim pogojem, izvedbo dekarboksilacije pod pogojem med nevtralnim in kislim, da dobimo N-(1(S)-etoksikarbonil-3-fenilpropil)-L-alanil-aminokislino in tvorbo njene farmakološko sprejemljive soli, v katerem proizvodnjo stranskega produkta (3) preprečimo tako, da v vodni tekočini izvedemo serijo operacij do tvorbe farmakološko sprejemljive soli ali do izolacije farmakološko sprejemljive soli. Predloženi izum omogoča pripravo farmakološko sprejemljive soli N-(1(S)- etoksikarbonil-3-fenilpropil)-L-alanil-aminokisline visoke kakovosti v tržnem merilu,z visokim dobitkom in z ekonomično učinkovitostjo.
-
-
-
-
-
-
-
-
-